🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05291728
Recruiting Observational

Screening for Early Gastric Cancer in Shaanxi Province

NCT05291728 · tracked via the Priya Life Science China tracker
Sponsor
Second Affiliated Hospital of Xi'an Jiaotong University
Phase
Observational
Started
2020-10-01
Last updated
2022-03-23

Condition(s) studied

Early Gastric Cancer

Study summary

This study collect the relevant data of local residents over 20 years old in 11 regions of Shaanxi Province, The basic information of the subjects was collected by filling in the questionnaire, and serum helicobacter pylori antibody detection was completed at the same time. The expert group determined the high-risk population of gastric cancer after comprehensive evaluation. All the high-risk population of gastric cancer without contraindications underwent electronic gastroscopy in the designated hospital after signing the informed consent. By collecting and analyzing data, early gastric cancer screening was completed and a new gastric cancer risk assessment model was established to evaluate the prevalence of dyspepsia, gastroesophageal reflux disease and precancerous lesions in the natural population of Shaanxi Province, as well as helicobacter pylori infection, radical treatment and recurrence rate.

Eligibility

Sex
ALL
Min age
20 Years
Max age
Healthy volunteers
Accepted
Inclusion Criteria: * Local resident over 20 years old. * Obtain verbal informed consent of the subject. Exclusion Criteria: * Refused to participate in this research project. * Questionnaires or serological tests for helicobacter pylori antibodies were not completed. * This study was not completed due to other reasons.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
The second affiliated hospital of xi'an jiaotong university Xi'an Shaanxi Recruiting

More Second Affiliated Hospital of Xi'an Jiaotong University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05291728 on ClinicalTrials.gov ↗ ← All trials in China